Incidence of 12 common cardiovascular diseases and subsequent mortality risk in the general population.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
26 10 2023
Historique:
received: 07 03 2023
revised: 25 05 2023
accepted: 03 06 2023
medline: 27 10 2023
pubmed: 9 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

Incident events of cardiovascular diseases (CVDs) are heterogenous and may result in different mortality risks. Such evidence may help inform patient and physician decisions in CVD prevention and risk factor management. This study aimed to determine the extent to which incident events of common CVD show heterogeneous associations with subsequent mortality risk in the general population. Based on England-wide linked electronic health records, we established a cohort of 1 310 518 people ≥30 years of age initially free of CVD and followed up for non-fatal events of 12 common CVD and cause-specific mortality. The 12 CVDs were considered as time-varying exposures in Cox's proportional hazards models to estimate hazard rate ratios (HRRs) with 95% confidence intervals (CIs). Over the median follow-up of 4.2 years (2010-16), 81 516 non-fatal CVD, 10 906 cardiovascular deaths, and 40 843 non-cardiovascular deaths occurred. All 12 CVDs were associated with increased risk of cardiovascular mortality, with HRR (95% CI) ranging from 1.67 (1.47-1.89) for stable angina to 7.85 (6.62-9.31) for haemorrhagic stroke. All 12 CVDs were also associated with increased non-cardiovascular and all-cause mortality risk but to a lesser extent: HRR (95% CI) ranged from 1.10 (1.00-1.22) to 4.55 (4.03-5.13) and from 1.24 (1.13-1.35) to 4.92 (4.44-5.46) for transient ischaemic attack and sudden cardiac arrest, respectively. Incident events of 12 common CVD show significant adverse and markedly differential associations with subsequent cardiovascular, non-cardiovascular, and all-cause mortality risk in the general population. We linked data available for 1.31 million people seen by English general practitioners in 2010 with data from hospital admissions and death certificates up to 2016 to investigate the risk of death in people who suffered from any of 12 common cardiovascular diseases (CVDs) compared with those who did not. The results show heterogeneously increased risks of death in people who suffered from any of 12 common CVD when compared with people who remained CVD free. The results support efforts of prevention for the entire spectrum of CVD including alleged minor types such as stable angina and transient ischaemic attack.

Sections du résumé

BACKGROUND
Incident events of cardiovascular diseases (CVDs) are heterogenous and may result in different mortality risks. Such evidence may help inform patient and physician decisions in CVD prevention and risk factor management.
AIMS
This study aimed to determine the extent to which incident events of common CVD show heterogeneous associations with subsequent mortality risk in the general population.
METHODS AND RESULTS
Based on England-wide linked electronic health records, we established a cohort of 1 310 518 people ≥30 years of age initially free of CVD and followed up for non-fatal events of 12 common CVD and cause-specific mortality. The 12 CVDs were considered as time-varying exposures in Cox's proportional hazards models to estimate hazard rate ratios (HRRs) with 95% confidence intervals (CIs). Over the median follow-up of 4.2 years (2010-16), 81 516 non-fatal CVD, 10 906 cardiovascular deaths, and 40 843 non-cardiovascular deaths occurred. All 12 CVDs were associated with increased risk of cardiovascular mortality, with HRR (95% CI) ranging from 1.67 (1.47-1.89) for stable angina to 7.85 (6.62-9.31) for haemorrhagic stroke. All 12 CVDs were also associated with increased non-cardiovascular and all-cause mortality risk but to a lesser extent: HRR (95% CI) ranged from 1.10 (1.00-1.22) to 4.55 (4.03-5.13) and from 1.24 (1.13-1.35) to 4.92 (4.44-5.46) for transient ischaemic attack and sudden cardiac arrest, respectively.
CONCLUSION
Incident events of 12 common CVD show significant adverse and markedly differential associations with subsequent cardiovascular, non-cardiovascular, and all-cause mortality risk in the general population.
We linked data available for 1.31 million people seen by English general practitioners in 2010 with data from hospital admissions and death certificates up to 2016 to investigate the risk of death in people who suffered from any of 12 common cardiovascular diseases (CVDs) compared with those who did not. The results show heterogeneously increased risks of death in people who suffered from any of 12 common CVD when compared with people who remained CVD free. The results support efforts of prevention for the entire spectrum of CVD including alleged minor types such as stable angina and transient ischaemic attack.

Autres résumés

Type: plain-language-summary (eng)
We linked data available for 1.31 million people seen by English general practitioners in 2010 with data from hospital admissions and death certificates up to 2016 to investigate the risk of death in people who suffered from any of 12 common cardiovascular diseases (CVDs) compared with those who did not. The results show heterogeneously increased risks of death in people who suffered from any of 12 common CVD when compared with people who remained CVD free. The results support efforts of prevention for the entire spectrum of CVD including alleged minor types such as stable angina and transient ischaemic attack.

Identifiants

pubmed: 37294923
pii: 7193310
doi: 10.1093/eurjpc/zwad192
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1715-1722

Subventions

Organisme : Medical Research Council
ID : MC_PC_20059
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Auteurs

Christof Prugger (C)

Institute of Public Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Marie-Cécile Perier (MC)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Diseases, Université Paris Cité, 56 rue Leblanc, 75015 Paris, France.

Arturo Gonzalez-Izquierdo (A)

Institute of Health Informatics, University College London, 222 Euston Road, NW1 2DA London, UK.
Health Data Research UK, 215 Euston Road, NW1 2DA London, UK.
UCL Hospitals Biomedical Research Centers (BRC), 270 Tottenham Court Road, 215 Euston Road, NW1 2BE London, UK.

Harry Hemingway (H)

Institute of Health Informatics, University College London, 222 Euston Road, NW1 2DA London, UK.
Health Data Research UK, 215 Euston Road, NW1 2DA London, UK.
UCL Hospitals Biomedical Research Centers (BRC), 270 Tottenham Court Road, 215 Euston Road, NW1 2BE London, UK.

Spiros Denaxas (S)

Institute of Health Informatics, University College London, 222 Euston Road, NW1 2DA London, UK.
Health Data Research UK, 215 Euston Road, NW1 2DA London, UK.
UCL Hospitals Biomedical Research Centers (BRC), 270 Tottenham Court Road, 215 Euston Road, NW1 2BE London, UK.
British Heart Foundation Data Science Center, 215 Euston Road, NW1 2BE London, UK.

Jean-Philippe Empana (JP)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Diseases, Université Paris Cité, 56 rue Leblanc, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH